MONTE ROSA THERAPEUTICS INC. - COMMON STOCK
4.1350
06-May-25 16:45:00
15 minutes delayed
Stocks
-0.4950
-10.69%
Today's range
4.1300 - 4.5900
ISIN
N/A
Source
NASDAQ
-
Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences
03 Feb 2022 16:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
02 Dec 2021 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
22 Nov 2021 07:30:00 By Nasdaq GlobeNewswire
-
10 Nov 2021 07:30:01 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Present at 4th Annual Targeted Protein Degradation Summit
20 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
07 Oct 2021 09:00:02 By Nasdaq GlobeNewswire
-
30 Sep 2021 16:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® Indexes
10 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference
08 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
12 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces Pricing of Initial Public Offering
23 Jun 2021 20:20:00 By Nasdaq GlobeNewswire